Scientists supercharge Patient's own cells to battle tough cancers
NCT ID NCT07224568
Summary
This early-stage study is testing a new type of cell therapy for adults with advanced solid tumors that have not responded to standard treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack their cancer, and then infuse them back into the patient. The main goals are to see if this process is safe and feasible, and to find the right dose for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for YOLK SAC TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutch Cancer Center
Seattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.